- Bestsellers
- Alcoholism
- COVID-19
- Allergy
- Anti Fungal
- Alzheimers
- Anti Viral
- Anti-Depressants
- Anti-Inflammatory
- Antibacterial
- Antiparasitic
- Antibiotics
- Arthritis
- Asthma
- Birth Control
- Blood Pressure
- Cancer
- Cardiovascular
- Cholesterol
- Diabetes
- Diuretics
- Erectile Dysfunction
- Eye Drop
- Gastro Health
- General Health
- Hair Loss
- Hepatitis C Virus (HCV)
- HIV
- Hormones
- Men's ED Packs
- Men's Health
- Mental Illness
- Motion Sickness
- Muscle Relaxant
- Pain Relief
- Parkinson’s Disease
- Veterinary Medicines
- Quit Smoking
- Vitamins
- Skin Care
- Sleeping Aids
- Weight Loss
- Women's Health
Generic Vaniqa ( Eflornithine )
Vaniqa (eflornithine hydrochloride) cream 13.9% is a topical hair growth retardant indicated for the reduction of unwanted facial hair in women. It works by irreversibly inhibiting the enzyme ornithine decarboxylase, which is essential for the synthesis of polyamines required for cell division in hair follicles. By slowing follicular cell proliferation, Vaniqa reduces the rate of facial hair growth and can make hair softer and less noticeable. It is not a depilatory and does not remove existing hair; patients should continue their usual hair removal method (e.g., shaving, plucking, waxing) while using Vaniqa. Improvement is gradual, and continued use is necessary to maintain benefit.
Usual adult dose: Apply a thin layer of Vaniqa cream to the affected areas of the face and under the chin, twice daily, at least 8 hours apart. The cream should be gently massaged into the skin until fully absorbed. The treated area should not be washed for at least 4 hours after application. Cosmetics, moisturizers, or sunscreens may be applied after the cream has dried. If no improvement is seen after 6 months of continuous use, treatment should be discontinued. If treatment is stopped, hair growth generally returns to pretreatment levels within 8 weeks. Vaniqa is for external use only and should not be applied to other body areas, eyes, nose, mouth, or broken skin. Hands should be washed after application.
Dosage form: Topical cream: 13.9% eflornithine hydrochloride (139 mg per gram of cream). Available in tubes of 15 g and 30 g. The cream is white to off-white and odourless.
Onset of action: A reduction in facial hair growth is typically observed after 4 to 8 weeks of continuous twice-daily use. Maximum benefit is generally achieved after 6 months of regular application. Because hair growth is slowed rather than eliminated, results are gradual and require ongoing treatment.
Duration of action: The clinical effect lasts only as long as the cream is applied regularly twice daily. If treatment is discontinued, hair growth returns to pretreatment levels within approximately 8 weeks. The elimination half-life of eflornithine after topical application is approximately 8 hours, but the pharmacodynamic effect on hair follicles is cumulative and requires continuous use.
Alcohol recommendation: There is no known systemic interaction between topical eflornithine and the consumption of alcoholic beverages. However, patients should avoid applying alcohol-based facial products, astringents, or peeling agents to the treated areas, as these can increase skin irritation, stinging, or burning. Moderation in alcohol consumption is advisable.
Most common side effects: The most frequently reported adverse effects are local skin reactions, including stinging, burning, tingling, erythema (redness), acne, rash, and folliculitis. These reactions are generally mild to moderate and often resolve with continued use or after discontinuation. Pseudofolliculitis barbae (ingrown hairs) may also occur, particularly in patients who continue to shave or pluck. Rarely, severe irritation, allergic contact dermatitis, or skin depigmentation may occur. Vaniqa should not be used by patients with known hypersensitivity to eflornithine or any component of the formulation. It is indicated only for facial hirsutism in women and is not recommended for use in men or children. Vaniqa is available only by prescription in Canada and should be used under the supervision of a healthcare professional.
Would you like to try Vaniqa (Eflornithine) without a prescription?
+ Next orders 10% discount
+ Next orders 10% discount
+ Next orders 10% discount
